Fabrus, LLC is a La Jolla, CA-based early-stage biotechnology company focused on discovering and developing antibody therapeutics. The company’s core work centers on identifying and developing antibody drug candidates. Fabrus recently secured external financing to advance its pipeline. Investors in the financing include OPKO Health, Frost Gamma Investments Trust and Hsu Gamma Investment, L.P. As part of the transaction, Phillip Frost, M.D., OPKO, and Jane Hsiao, Vice Chairman and CTO of OPKO, joined Fabrus’ Board of Managers. The funds will be used to develop drug candidates.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2010